Re-engineering the adenine deaminase TadA-8e for efficient and specific CRISPR-based cytosine base editing

Nat Biotechnol. 2023 May;41(5):663-672. doi: 10.1038/s41587-022-01532-7. Epub 2022 Nov 10.

Abstract

Cytosine base editors (CBEs) efficiently generate precise C·G-to-T·A base conversions, but the activation-induced cytidine deaminase/apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like (AID/APOBEC) protein family deaminase component induces considerable off-target effects and indels. To explore unnatural cytosine deaminases, we repurpose the adenine deaminase TadA-8e for cytosine conversion. The introduction of an N46L variant in TadA-8e eliminates its adenine deaminase activity and results in a TadA-8e-derived C-to-G base editor (Td-CGBE) capable of highly efficient and precise C·G-to-G·C editing. Through fusion with uracil glycosylase inhibitors and further introduction of additional variants, a series of Td-CBEs was obtained either with a high activity similar to that of BE4max or with higher precision compared to other reported accurate CBEs. Td-CGBE/Td-CBEs show very low indel effects and a background level of Cas9-dependent or Cas9-independent DNA/RNA off-target editing. Moreover, Td-CGBE/Td-CBEs are more efficient in generating accurate edits in homopolymeric cytosine sites in cells or mouse embryos, suggesting their accuracy and safety for gene therapy and other applications.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminohydrolases / metabolism
  • Animals
  • CRISPR-Cas Systems / genetics
  • Cytidine Deaminase / genetics
  • Cytidine Deaminase / metabolism
  • Cytosine* / metabolism
  • Gene Editing* / methods
  • Mice
  • RNA

Substances

  • adenine deaminase
  • Cytosine
  • Aminohydrolases
  • RNA
  • Cytidine Deaminase